NCT03784261

Usefulness of Non TNF Usage in RA Patients

Usefulness of Non TNF Usage in Rheumatoid Arthritis Patients

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Shinshu University · Academic / Other
• Sex: All
• Age: 20 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to examine the efficacy and adverse events in the following 3 groups in rheumatoid arthritis patients: 1. Sarilumab treatment for 12 months 2. Tocilizmab treatment for 12 months 3. Abatacept treatment for 12 months

Conditions

• Rheumatoid Arthritis

Interventions

Type	Name	Description
DRUG	Drug: "Salirumab"	To examine the effects of salirumab in RA patients
DRUG	Drug: "Tocilizmab"	To examine the effects of tocilizmab in RA patients
DRUG	Drug: "Abatacept"	To examine the effects of abatacept in RA patients

Timeline

• Start date: 2018-12-17
• Primary completion: 2022-12-16
• Completion: 2024-12-16
• First posted: 2018-12-21
• Last updated: 2021-09-21

Locations

1 site across 1 country: Japan